| Revenue guidance | 5.9% → 15.0% Raised by 9.1 percentage points |
|---|---|
| Management target | Revenue 15.0% FY28 |
| Revenue growth | 34% YoY growth in Q1 FY27. |
|---|---|
| Margins | EBITDA margin expanded 260 bps to 19.3%. |
| Order book | Firm contracts for lithium electrolyte salts with four international customers. |
| Demand visibility | Strong international demand for non-FEOC compliant battery materials. |
| Management confidence | High, citing strong volume growth and peak organo-lithium utilization. |
Growth
Q1 FY27 revenue at ₹250 crore (up 34% YoY); PAT surged 67% to ₹17.1 crore.
Outlook
Standalone FY27 revenue guidance raised to ₹950-1,050 crore. Targeting ₹2,400-2,900 crore total revenue by FY29.
Risks
Global supply chain volatility, elevated freight costs, and dependency on lithium price pass-through mechanisms.
Last quarter's promises, checked
Delivered
- Guided standalone FY27 revenue ₹875-950cr → delivered guidance raise to ₹950-1,050cr (= BEAT)
- Targeted electrolyte plant trial runs in Q1 FY27 → delivered trial runs initiated (= BEAT)
- Guided volume-driven growth strategy → delivered 34% revenue growth led by volume (= BEAT)
Partly delivered
- Targeted commercial production Q2 FY27 → delivered trial phase; commercial start imminent (= PARTIAL)
Earnings Call Transcript filed with BSE, NSE: NEOGEN. Summary written with AI assistance from the document.
Neogen Chemicals Ltd: key numbers
- Share price
- ₹2,385.20
- Market cap
- ₹7,166 Cr
- Revenue (annual)
- ₹862.0 Cr
- Net profit (annual)
- ₹28.75 Cr
- P/E (TTM)
- 201.5×Sector 37.5×
- Promoter holding
- 48.31%-2.92% QoQ
- FII holding
- 4.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neogen Chemicals Ltd
All →Neogen Chemicals Capital Structure Change
Neogen Chemicals' subsidiary, Neogen Morita New Materials Limited, approved a preferential issue of 7,20,000 equity shares worth ₹76.80 Crore to Morita Investment Limited.
- Value
- ₹76.80 Cr
Neogen Chemicals Credit Rating
CRISIL Ratings reaffirmed and revised outlooks for Neogen Chemicals and subsidiary Neogen Ionics' facilities and debt, citing improved financial risk profile and completed QIP funding.
Neogen Chemicals Debt & Borrowing: ₹1.63 Cr
Neogen Chemicals has paid the interest on its listed non-convertible debentures for September 2026, totaling ₹1.63 Crore.
- Value
- ₹1.63 Cr
Neogen Chemicals Other Announcement
Neogen Chemicals Ltd has submitted its quarterly shareholding pattern disclosure as per SEBI regulations. This routine filing details the current equity distribution among promoters and public shareholders.
Neogen Chemicals Capital Structure Change
Neogen Chemicals Limited allotted equity shares via a Qualified Institutional Placement (QIP). The allotment increases the total paid-up share capital of the company.
Neogen Chemicals Fund Raise of ₹600 Cr
Neogen Chemicals is raising funds via a Qualified Institutional Placement of 26.61 lakh equity shares. This issuance is valued at approximately ₹600 Crore.
- Value
- ₹600.0 Cr